157 related articles for article (PubMed ID: 26159204)
1. Quantitative μPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
Waldron AM; Wyffels L; Verhaeghe J; Bottelbergs A; Richardson J; Kelley J; Schmidt M; Stroobants S; Langlois X; Staelens S
Curr Alzheimer Res; 2015; 12(7):694-703. PubMed ID: 26159204
[TBL] [Abstract][Full Text] [Related]
2. In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice.
Waldron AM; Wintmolders C; Bottelbergs A; Kelley JB; Schmidt ME; Stroobants S; Langlois X; Staelens S
Alzheimers Res Ther; 2015 Dec; 7(1):76. PubMed ID: 26666747
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.
Waldron AM; Wyffels L; Verhaeghe J; Richardson JC; Schmidt M; Stroobants S; Langlois X; Staelens S
J Alzheimers Dis; 2017; 55(4):1537-1548. PubMed ID: 27911309
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
5. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
Sang S; Pan X; Chen Z; Zeng F; Pan S; Liu H; Jin L; Fei G; Wang C; Ren S; Jiao F; Bao W; Zhou W; Guan Y; Zhang Y; Shi H; Wang Y; Yu X; Wang Y; Zhong C
Alzheimers Res Ther; 2018 Mar; 10(1):26. PubMed ID: 29490669
[TBL] [Abstract][Full Text] [Related]
6. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease.
Kuntner C; Kesner AL; Bauer M; Kremslehner R; Wanek T; Mandler M; Karch R; Stanek J; Wolf T; Müller M; Langer O
Mol Imaging Biol; 2009; 11(4):236-40. PubMed ID: 19214638
[TBL] [Abstract][Full Text] [Related]
7. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
8. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
[TBL] [Abstract][Full Text] [Related]
9. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease.
Deleye S; Waldron AM; Verhaeghe J; Bottelbergs A; Wyffels L; Van Broeck B; Langlois X; Schmidt M; Stroobants S; Staelens S
J Nucl Med; 2017 Dec; 58(12):1977-1983. PubMed ID: 28611242
[TBL] [Abstract][Full Text] [Related]
11. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
[TBL] [Abstract][Full Text] [Related]
12. Effect of genotype and age on cerebral [
Snellman A; Takkinen JS; López-Picón FR; Eskola O; Solin O; Rinne JO; Haaparanta-Solin M
Sci Rep; 2019 Apr; 9(1):5700. PubMed ID: 30952945
[TBL] [Abstract][Full Text] [Related]
13. Early detection of cerebral glucose uptake changes in the 5XFAD mouse.
Macdonald IR; DeBay DR; Reid GA; O'Leary TP; Jollymore CT; Mawko G; Burrell S; Martin E; Bowen CV; Brown RE; Darvesh S
Curr Alzheimer Res; 2014; 11(5):450-60. PubMed ID: 24801216
[TBL] [Abstract][Full Text] [Related]
14. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography.
Rojas S; Herance JR; Gispert JD; Abad S; Torrent E; Jiménez X; Pareto D; Perpiña U; Sarroca S; Rodríguez E; Ortega-Aznar A; Sanfeliu C
Neurobiol Aging; 2013 Jul; 34(7):1790-8. PubMed ID: 23402900
[TBL] [Abstract][Full Text] [Related]
16. Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.
Poisnel G; Hérard AS; El Tannir El Tayara N; Bourrin E; Volk A; Kober F; Delatour B; Delzescaux T; Debeir T; Rooney T; Benavides J; Hantraye P; Dhenain M
Neurobiol Aging; 2012 Sep; 33(9):1995-2005. PubMed ID: 22079157
[TBL] [Abstract][Full Text] [Related]
17. Comparability of [
Rodriguez-Vieitez E; Leuzy A; Chiotis K; Saint-Aubert L; Wall A; Nordberg A
J Cereb Blood Flow Metab; 2017 Feb; 37(2):740-749. PubMed ID: 27107028
[TBL] [Abstract][Full Text] [Related]
18. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Dubois A; Hérard AS; Delatour B; Hantraye P; Bonvento G; Dhenain M; Delzescaux T
Neuroimage; 2010 Jun; 51(2):586-98. PubMed ID: 20206704
[TBL] [Abstract][Full Text] [Related]
19. Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer's disease.
Thientunyakit T; Sethanandha C; Muangpaisan W; Chawalparit O; Arunrungvichian K; Siriprapa T; Vichianin Y; Kamal S; Suppasilp C; Thongpraparn T; Chanachai R; Gelovani JG
Ann Nucl Med; 2020 May; 34(5):337-348. PubMed ID: 32152925
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model.
Deleye S; Waldron AM; Richardson JC; Schmidt M; Langlois X; Stroobants S; Staelens S
Mol Imaging; 2016; 15():. PubMed ID: 27030402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
